Skip to main content
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
20.17
-6.50 (-24.37%)
At close: Mar 28, 2025, 4:00 PM
20.04
-0.13 (-0.64%)
After-hours: Mar 28, 2025, 7:59 PM EDT

TNXP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
10.097.77---
Upgrade
Revenue Growth (YoY)
29.94%----
Upgrade
Cost of Revenue
7.774.74---
Upgrade
Gross Profit
2.333.03---
Upgrade
Selling, General & Admin
40.134.7530.2223.4714.35
Upgrade
Research & Development
39.9786.6681.8868.8436.16
Upgrade
Operating Expenses
80.07121.41112.0992.3150.51
Upgrade
Operating Income
-77.74-118.38-112.09-92.31-50.51
Upgrade
Interest & Investment Income
---0.030.05
Upgrade
Other Non Operating Income (Expenses)
6.671.721.87--
Upgrade
EBT Excluding Unusual Items
-71.08-116.66-110.22-92.29-50.46
Upgrade
Impairment of Goodwill
-1----
Upgrade
Asset Writedown
-57.96----
Upgrade
Pretax Income
-130.04-116.66-110.22-92.29-50.46
Upgrade
Net Income
-130.04-116.66-110.22-92.29-50.46
Upgrade
Preferred Dividends & Other Adjustments
--6.66-1.71
Upgrade
Net Income to Common
-130.04-116.66-116.88-92.29-52.17
Upgrade
Shares Outstanding (Basic)
1----
Upgrade
Shares Outstanding (Diluted)
1----
Upgrade
EPS (Basic)
-176.60----
Upgrade
EPS (Diluted)
-176.60----
Upgrade
Free Cash Flow
-61.05-109.9-146.2-110.86-57.13
Upgrade
Free Cash Flow Per Share
-82.90----
Upgrade
Gross Margin
23.07%38.97%---
Upgrade
Operating Margin
-770.20%-1523.94%---
Upgrade
Profit Margin
-1288.25%-1501.78%---
Upgrade
Free Cash Flow Margin
-604.76%-1414.75%---
Upgrade
EBITDA
-74.32-114.09-110.84-92.26-50.48
Upgrade
D&A For EBITDA
3.424.291.250.050.03
Upgrade
EBIT
-77.74-118.38-112.09-92.31-50.51
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q